A practitioner is assessed. The award is issued as a Q-Pass. The clinic checks it before anyone treats a patient.

The clinic package — £1,750 excl. VAT

Practitioner assessed against The Injectable Delegation & Authority Standard v1.0. The award is issued as a Q-Pass — a signed, revocable record — and the clinic checks it before anyone treats a patient. The check the clinic runs is observing-class: it informs, and the clinic’s own policy decides.

The assessment fee is £150 excl. VAT, identical whether the practitioner passes or fails. A failed assessment is not refunded, and this is stated before purchase. The fail rate is published.

Founding places: 2, as of August 2026 — relieved when the clinical reviewer signs the standard. A founding place is £500 excl. VAT and buys the queue position; it says so on the order.

What the clinic gets

Founding places: 2, as of August 2026 — relieved when the clinical reviewer signs the standard.

The founding place is £500. It is a different purchase from the package: it buys standing and a position at the front of the queue, nothing more, and it says so. No assessment is sold — to anyone, at any price — until The Injectable Delegation & Authority Standard v1.0 is reviewed and signed by the named registered prescriber. When the signature lands, the queue moves.

There is no deadline on this and no countdown behind it. Capacity is a fact about now; a cap is a promise not to grow, and this institution makes no such promise.